0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Bacille Calmette-Guérin Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-12G12966
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Bacille Calmette Guérin Vaccine Market Research Report 2023
BUY CHAPTERS

Bacille Calmette-Guérin Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-12G12966
Report
September 2024
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Bacille Calmette-Guérin Vaccine - Market Size

The global market for Bacille Calmette-Guérin Vaccine was estimated to be worth US$ 149 million in 2023 and is forecast to a readjusted size of US$ 295.5 million by 2030 with a CAGR of 6.2% during the forecast period 2024-2030

Bacille Calmette-Guérin Vaccine - Market

Bacille Calmette-Guérin Vaccine - Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Bacille Calmette-Guérin Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Bacille Calmette-Guérin Vaccine by region & country, by Type, and by Application.
The Bacille Calmette-Guérin Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacille Calmette-Guérin Vaccine.
Market Segmentation

Scope of Bacille Calmette-Guérin Vaccine - Market Report

Report Metric Details
Report Name Bacille Calmette-Guérin Vaccine - Market
Forecasted market size in 2030 US$ 295.5 million
CAGR 6.2%
Forecasted years 2024 - 2030
Segment by Type:
  • Immune Bacille Calmette-Guérin
  • Therapy Bacille Calmette-Guérin
Segment by Application
  • Infants Under 3 Months
  • Children Test Negative With 5IUPPD
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, GSBPL
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Bacille Calmette-Guérin Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Bacille Calmette-Guérin Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Bacille Calmette-Guérin Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Bacille Calmette-Guérin Vaccine - Market size in 2030?

Ans: The Bacille Calmette-Guérin Vaccine - Market size in 2030 will be US$ 295.5 million.

Who are the main players in the Bacille Calmette-Guérin Vaccine - Market report?

Ans: The main players in the Bacille Calmette-Guérin Vaccine - Market are Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, GSBPL

What are the Application segmentation covered in the Bacille Calmette-Guérin Vaccine - Market report?

Ans: The Applications covered in the Bacille Calmette-Guérin Vaccine - Market report are Infants Under 3 Months, Children Test Negative With 5IUPPD

What are the Type segmentation covered in the Bacille Calmette-Guérin Vaccine - Market report?

Ans: The Types covered in the Bacille Calmette-Guérin Vaccine - Market report are Immune Bacille Calmette-Guérin, Therapy Bacille Calmette-Guérin

Recommended Reports

Human Vaccines

Vaccine Technologies

Animal Vaccines

1 Market Overview
1.1 Bacille Calmette-Guérin Vaccine Product Introduction
1.2 Global Bacille Calmette-Guérin Vaccine Market Size Forecast
1.2.1 Global Bacille Calmette-Guérin Vaccine Sales Value (2019-2030)
1.2.2 Global Bacille Calmette-Guérin Vaccine Sales Volume (2019-2030)
1.2.3 Global Bacille Calmette-Guérin Vaccine Sales Price (2019-2030)
1.3 Bacille Calmette-Guérin Vaccine Market Trends & Drivers
1.3.1 Bacille Calmette-Guérin Vaccine Industry Trends
1.3.2 Bacille Calmette-Guérin Vaccine Market Drivers & Opportunity
1.3.3 Bacille Calmette-Guérin Vaccine Market Challenges
1.3.4 Bacille Calmette-Guérin Vaccine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Bacille Calmette-Guérin Vaccine Players Revenue Ranking (2023)
2.2 Global Bacille Calmette-Guérin Vaccine Revenue by Company (2019-2024)
2.3 Global Bacille Calmette-Guérin Vaccine Players Sales Volume Ranking (2023)
2.4 Global Bacille Calmette-Guérin Vaccine Sales Volume by Company Players (2019-2024)
2.5 Global Bacille Calmette-Guérin Vaccine Average Price by Company (2019-2024)
2.6 Key Manufacturers Bacille Calmette-Guérin Vaccine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Bacille Calmette-Guérin Vaccine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Bacille Calmette-Guérin Vaccine
2.9 Bacille Calmette-Guérin Vaccine Market Competitive Analysis
2.9.1 Bacille Calmette-Guérin Vaccine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Bacille Calmette-Guérin Vaccine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacille Calmette-Guérin Vaccine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Immune Bacille Calmette-Guérin
3.1.2 Therapy Bacille Calmette-Guérin
3.2 Global Bacille Calmette-Guérin Vaccine Sales Value by Type
3.2.1 Global Bacille Calmette-Guérin Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Bacille Calmette-Guérin Vaccine Sales Value, by Type (2019-2030)
3.2.3 Global Bacille Calmette-Guérin Vaccine Sales Value, by Type (%) (2019-2030)
3.3 Global Bacille Calmette-Guérin Vaccine Sales Volume by Type
3.3.1 Global Bacille Calmette-Guérin Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Bacille Calmette-Guérin Vaccine Sales Volume, by Type (2019-2030)
3.3.3 Global Bacille Calmette-Guérin Vaccine Sales Volume, by Type (%) (2019-2030)
3.4 Global Bacille Calmette-Guérin Vaccine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Infants Under 3 Months
4.1.2 Children Test Negative With 5IUPPD
4.2 Global Bacille Calmette-Guérin Vaccine Sales Value by Application
4.2.1 Global Bacille Calmette-Guérin Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Bacille Calmette-Guérin Vaccine Sales Value, by Application (2019-2030)
4.2.3 Global Bacille Calmette-Guérin Vaccine Sales Value, by Application (%) (2019-2030)
4.3 Global Bacille Calmette-Guérin Vaccine Sales Volume by Application
4.3.1 Global Bacille Calmette-Guérin Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Bacille Calmette-Guérin Vaccine Sales Volume, by Application (2019-2030)
4.3.3 Global Bacille Calmette-Guérin Vaccine Sales Volume, by Application (%) (2019-2030)
4.4 Global Bacille Calmette-Guérin Vaccine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Bacille Calmette-Guérin Vaccine Sales Value by Region
5.1.1 Global Bacille Calmette-Guérin Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Bacille Calmette-Guérin Vaccine Sales Value by Region (2019-2024)
5.1.3 Global Bacille Calmette-Guérin Vaccine Sales Value by Region (2025-2030)
5.1.4 Global Bacille Calmette-Guérin Vaccine Sales Value by Region (%), (2019-2030)
5.2 Global Bacille Calmette-Guérin Vaccine Sales Volume by Region
5.2.1 Global Bacille Calmette-Guérin Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Bacille Calmette-Guérin Vaccine Sales Volume by Region (2019-2024)
5.2.3 Global Bacille Calmette-Guérin Vaccine Sales Volume by Region (2025-2030)
5.2.4 Global Bacille Calmette-Guérin Vaccine Sales Volume by Region (%), (2019-2030)
5.3 Global Bacille Calmette-Guérin Vaccine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Bacille Calmette-Guérin Vaccine Sales Value, 2019-2030
5.4.2 North America Bacille Calmette-Guérin Vaccine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Bacille Calmette-Guérin Vaccine Sales Value, 2019-2030
5.5.2 Europe Bacille Calmette-Guérin Vaccine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Bacille Calmette-Guérin Vaccine Sales Value, 2019-2030
5.6.2 Asia Pacific Bacille Calmette-Guérin Vaccine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Bacille Calmette-Guérin Vaccine Sales Value, 2019-2030
5.7.2 South America Bacille Calmette-Guérin Vaccine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Bacille Calmette-Guérin Vaccine Sales Value, 2019-2030
5.8.2 Middle East & Africa Bacille Calmette-Guérin Vaccine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Bacille Calmette-Guérin Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Bacille Calmette-Guérin Vaccine Sales Value
6.2.1 Key Countries/Regions Bacille Calmette-Guérin Vaccine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Bacille Calmette-Guérin Vaccine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Bacille Calmette-Guérin Vaccine Sales Value, 2019-2030
6.3.2 United States Bacille Calmette-Guérin Vaccine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Bacille Calmette-Guérin Vaccine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Bacille Calmette-Guérin Vaccine Sales Value, 2019-2030
6.4.2 Europe Bacille Calmette-Guérin Vaccine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Bacille Calmette-Guérin Vaccine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Bacille Calmette-Guérin Vaccine Sales Value, 2019-2030
6.5.2 China Bacille Calmette-Guérin Vaccine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Bacille Calmette-Guérin Vaccine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Bacille Calmette-Guérin Vaccine Sales Value, 2019-2030
6.6.2 Japan Bacille Calmette-Guérin Vaccine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Bacille Calmette-Guérin Vaccine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Bacille Calmette-Guérin Vaccine Sales Value, 2019-2030
6.7.2 South Korea Bacille Calmette-Guérin Vaccine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Bacille Calmette-Guérin Vaccine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Bacille Calmette-Guérin Vaccine Sales Value, 2019-2030
6.8.2 Southeast Asia Bacille Calmette-Guérin Vaccine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Bacille Calmette-Guérin Vaccine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Bacille Calmette-Guérin Vaccine Sales Value, 2019-2030
6.9.2 India Bacille Calmette-Guérin Vaccine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Bacille Calmette-Guérin Vaccine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Merck
7.1.1 Merck Company Information
7.1.2 Merck Introduction and Business Overview
7.1.3 Merck Bacille Calmette-Guérin Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Merck Bacille Calmette-Guérin Vaccine Product Offerings
7.1.5 Merck Recent Development
7.2 Sanofi Pasteur
7.2.1 Sanofi Pasteur Company Information
7.2.2 Sanofi Pasteur Introduction and Business Overview
7.2.3 Sanofi Pasteur Bacille Calmette-Guérin Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Sanofi Pasteur Bacille Calmette-Guérin Vaccine Product Offerings
7.2.5 Sanofi Pasteur Recent Development
7.3 Japan BCG Lab
7.3.1 Japan BCG Lab Company Information
7.3.2 Japan BCG Lab Introduction and Business Overview
7.3.3 Japan BCG Lab Bacille Calmette-Guérin Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Japan BCG Lab Bacille Calmette-Guérin Vaccine Product Offerings
7.3.5 Japan BCG Lab Recent Development
7.4 China National Biotec
7.4.1 China National Biotec Company Information
7.4.2 China National Biotec Introduction and Business Overview
7.4.3 China National Biotec Bacille Calmette-Guérin Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 China National Biotec Bacille Calmette-Guérin Vaccine Product Offerings
7.4.5 China National Biotec Recent Development
7.5 Serum Institute of India
7.5.1 Serum Institute of India Company Information
7.5.2 Serum Institute of India Introduction and Business Overview
7.5.3 Serum Institute of India Bacille Calmette-Guérin Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Serum Institute of India Bacille Calmette-Guérin Vaccine Product Offerings
7.5.5 Serum Institute of India Recent Development
7.6 GSBPL
7.6.1 GSBPL Company Information
7.6.2 GSBPL Introduction and Business Overview
7.6.3 GSBPL Bacille Calmette-Guérin Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 GSBPL Bacille Calmette-Guérin Vaccine Product Offerings
7.6.5 GSBPL Recent Development
8 Industry Chain Analysis
8.1 Bacille Calmette-Guérin Vaccine Industrial Chain
8.2 Bacille Calmette-Guérin Vaccine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Bacille Calmette-Guérin Vaccine Sales Model
8.5.2 Sales Channel
8.5.3 Bacille Calmette-Guérin Vaccine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Bacille Calmette-Guérin Vaccine Market Trends
    Table 2. Bacille Calmette-Guérin Vaccine Market Drivers & Opportunity
    Table 3. Bacille Calmette-Guérin Vaccine Market Challenges
    Table 4. Bacille Calmette-Guérin Vaccine Market Restraints
    Table 5. Global Bacille Calmette-Guérin Vaccine Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Bacille Calmette-Guérin Vaccine Revenue Market Share by Company (2019-2024)
    Table 7. Global Bacille Calmette-Guérin Vaccine Sales Volume by Company (2019-2024) & (Units)
    Table 8. Global Bacille Calmette-Guérin Vaccine Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Bacille Calmette-Guérin Vaccine Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Bacille Calmette-Guérin Vaccine Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Bacille Calmette-Guérin Vaccine Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Bacille Calmette-Guérin Vaccine
    Table 13. Global Bacille Calmette-Guérin Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacille Calmette-Guérin Vaccine as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Bacille Calmette-Guérin Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Bacille Calmette-Guérin Vaccine Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Bacille Calmette-Guérin Vaccine Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Bacille Calmette-Guérin Vaccine Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Bacille Calmette-Guérin Vaccine Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Bacille Calmette-Guérin Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (Units)
    Table 22. Global Bacille Calmette-Guérin Vaccine Sales Volume by Type (2019-2024) & (Units)
    Table 23. Global Bacille Calmette-Guérin Vaccine Sales Volume by Type (2025-2030) & (Units)
    Table 24. Global Bacille Calmette-Guérin Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Bacille Calmette-Guérin Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Bacille Calmette-Guérin Vaccine Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Bacille Calmette-Guérin Vaccine Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Bacille Calmette-Guérin Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Bacille Calmette-Guérin Vaccine Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Bacille Calmette-Guérin Vaccine Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Bacille Calmette-Guérin Vaccine Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Bacille Calmette-Guérin Vaccine Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Bacille Calmette-Guérin Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (Units)
    Table 34. Global Bacille Calmette-Guérin Vaccine Sales Volume by Application (2019-2024) & (Units)
    Table 35. Global Bacille Calmette-Guérin Vaccine Sales Volume by Application (2025-2030) & (Units)
    Table 36. Global Bacille Calmette-Guérin Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Bacille Calmette-Guérin Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Bacille Calmette-Guérin Vaccine Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Bacille Calmette-Guérin Vaccine Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Bacille Calmette-Guérin Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Bacille Calmette-Guérin Vaccine Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Bacille Calmette-Guérin Vaccine Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Bacille Calmette-Guérin Vaccine Sales Value by Region (2019-2024) & (%)
    Table 44. Global Bacille Calmette-Guérin Vaccine Sales Value by Region (2025-2030) & (%)
    Table 45. Global Bacille Calmette-Guérin Vaccine Sales Volume by Region (Units): 2019 VS 2023 VS 2030
    Table 46. Global Bacille Calmette-Guérin Vaccine Sales Volume by Region (2019-2024) & (Units)
    Table 47. Global Bacille Calmette-Guérin Vaccine Sales Volume by Region (2025-2030) & (Units)
    Table 48. Global Bacille Calmette-Guérin Vaccine Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Bacille Calmette-Guérin Vaccine Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Bacille Calmette-Guérin Vaccine Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Bacille Calmette-Guérin Vaccine Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Bacille Calmette-Guérin Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Bacille Calmette-Guérin Vaccine Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Bacille Calmette-Guérin Vaccine Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Bacille Calmette-Guérin Vaccine Sales Volume, (2019-2024) & (Units)
    Table 56. Key Countries/Regions Bacille Calmette-Guérin Vaccine Sales Volume, (2025-2030) & (Units)
    Table 57. Merck Company Information
    Table 58. Merck Introduction and Business Overview
    Table 59. Merck Bacille Calmette-Guérin Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Merck Bacille Calmette-Guérin Vaccine Product Offerings
    Table 61. Merck Recent Development
    Table 62. Sanofi Pasteur Company Information
    Table 63. Sanofi Pasteur Introduction and Business Overview
    Table 64. Sanofi Pasteur Bacille Calmette-Guérin Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Sanofi Pasteur Bacille Calmette-Guérin Vaccine Product Offerings
    Table 66. Sanofi Pasteur Recent Development
    Table 67. Japan BCG Lab Company Information
    Table 68. Japan BCG Lab Introduction and Business Overview
    Table 69. Japan BCG Lab Bacille Calmette-Guérin Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Japan BCG Lab Bacille Calmette-Guérin Vaccine Product Offerings
    Table 71. Japan BCG Lab Recent Development
    Table 72. China National Biotec Company Information
    Table 73. China National Biotec Introduction and Business Overview
    Table 74. China National Biotec Bacille Calmette-Guérin Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. China National Biotec Bacille Calmette-Guérin Vaccine Product Offerings
    Table 76. China National Biotec Recent Development
    Table 77. Serum Institute of India Company Information
    Table 78. Serum Institute of India Introduction and Business Overview
    Table 79. Serum Institute of India Bacille Calmette-Guérin Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Serum Institute of India Bacille Calmette-Guérin Vaccine Product Offerings
    Table 81. Serum Institute of India Recent Development
    Table 82. GSBPL Company Information
    Table 83. GSBPL Introduction and Business Overview
    Table 84. GSBPL Bacille Calmette-Guérin Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. GSBPL Bacille Calmette-Guérin Vaccine Product Offerings
    Table 86. GSBPL Recent Development
    Table 87. Key Raw Materials Lists
    Table 88. Raw Materials Key Suppliers Lists
    Table 89. Bacille Calmette-Guérin Vaccine Downstream Customers
    Table 90. Bacille Calmette-Guérin Vaccine Distributors List
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Bacille Calmette-Guérin Vaccine Product Picture
    Figure 2. Global Bacille Calmette-Guérin Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Bacille Calmette-Guérin Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Bacille Calmette-Guérin Vaccine Sales Volume (2019-2030) & (Units)
    Figure 5. Global Bacille Calmette-Guérin Vaccine Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Bacille Calmette-Guérin Vaccine Report Years Considered
    Figure 7. Global Bacille Calmette-Guérin Vaccine Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Bacille Calmette-Guérin Vaccine Players Sales Volume Ranking (2023) & (Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Bacille Calmette-Guérin Vaccine Revenue in 2023
    Figure 10. Bacille Calmette-Guérin Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Immune Bacille Calmette-Guérin Picture
    Figure 12. Therapy Bacille Calmette-Guérin Picture
    Figure 13. Global Bacille Calmette-Guérin Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Bacille Calmette-Guérin Vaccine Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Bacille Calmette-Guérin Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (Units)
    Figure 16. Global Bacille Calmette-Guérin Vaccine Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Bacille Calmette-Guérin Vaccine Price by Type (2019-2030) & (US$/Unit)
    Figure 18. Product Picture of Infants Under 3 Months
    Figure 19. Product Picture of Children Test Negative With 5IUPPD
    Figure 20. Global Bacille Calmette-Guérin Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Bacille Calmette-Guérin Vaccine Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Bacille Calmette-Guérin Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (Units)
    Figure 23. Global Bacille Calmette-Guérin Vaccine Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Bacille Calmette-Guérin Vaccine Price by Application (2019-2030) & (US$/Unit)
    Figure 25. North America Bacille Calmette-Guérin Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Bacille Calmette-Guérin Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Bacille Calmette-Guérin Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Bacille Calmette-Guérin Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Bacille Calmette-Guérin Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Bacille Calmette-Guérin Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Bacille Calmette-Guérin Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Bacille Calmette-Guérin Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Bacille Calmette-Guérin Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Bacille Calmette-Guérin Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Bacille Calmette-Guérin Vaccine Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Bacille Calmette-Guérin Vaccine Sales Volume (%), (2019-2030)
    Figure 37. United States Bacille Calmette-Guérin Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Bacille Calmette-Guérin Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Bacille Calmette-Guérin Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Bacille Calmette-Guérin Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Bacille Calmette-Guérin Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Bacille Calmette-Guérin Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Bacille Calmette-Guérin Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Bacille Calmette-Guérin Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Bacille Calmette-Guérin Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Bacille Calmette-Guérin Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Bacille Calmette-Guérin Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Bacille Calmette-Guérin Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Bacille Calmette-Guérin Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Bacille Calmette-Guérin Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Bacille Calmette-Guérin Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Bacille Calmette-Guérin Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Bacille Calmette-Guérin Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Bacille Calmette-Guérin Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Bacille Calmette-Guérin Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Bacille Calmette-Guérin Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Bacille Calmette-Guérin Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 58. Bacille Calmette-Guérin Vaccine Industrial Chain
    Figure 59. Bacille Calmette-Guérin Vaccine Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS